Trade Event Partnership Program at HealthTechX Asia 2025

The US Commercial Service is partnering with HealthTechX Asia 2025 in Singapore May 21-22, 2025 through the Trade Events Partnership Program. 

US Companies are well positioned to enter Asia’s health technology market, projected to be worth USD143B in 2024 with a CAGR of 23.3% to 2033 compared to a 4.83% CAGR in the US or 15% CAGR globally. By participating in HealthTechX Asia, U.S. companies can leverage a world-class platform to build relationships, gain insights, and drive business growth in one of the most dynamic healthcare markets globally.

Check out our recent webinar recording: Access to Asia’s Rapidly Growing Health Technology Market to learn more about market entry! 

Hear from Dr Stephanie Ko, a consultant in Advanced Internal Medicine at the National University Hospital. With an interest in improving delivery of healthcare to the evolving population, she has been serving as the Lead for NUHS@Home since 2020 to deliver hospital-level care beyond the hospital walls at NUHS. Alongside the development of the clinical service, Dr. Ko also leads a collaborative research group to evaluate the implementation and scaling of Hospital-at-Home care models. 

Also featuring Feras Mahdi, a Partner at L.E.K., a global management consulting firm, with over 20 years of experience in healthcare and consulting across 25+ countries, primarily in APAC and MEA. He advises global MedTech companies and large healthcare institutions on corporate and business strategies, and works closely with governments and international agencies on public health policies, particularly around technology deployment and its impact. In addition to his corporate work, Dr. Mahdi mentors multiple startups, helping foster innovation in healthcare. Dr. Mahdi has held leadership roles at multinational MedTech companies like Medtronic and GE Healthcare, and led the APAC MedTech practice at IQVIA, an international healthcare & life sciences consulting firm. He is currently based in Singapore. He holds an MD with a specialization in Internal Medicine from the American University of Beirut and a Masters in BioScience Enterprise from the Judge Business School, University of Cambridge.